Several alternatives to mechlorethamine exist, depending on the type of cancer and patient-specific factors. Other alkylating agents such as cyclophosphamide and ifosfamide may be used. Additionally, newer targeted therapies and immunotherapies have shown promise in treating various types of cancers. Discussing these options with a healthcare provider can help determine the most appropriate treatment plan.
